Page last updated: 2024-10-31

metyrapone and Crohn Disease

metyrapone has been researched along with Crohn Disease in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
REED, PI1
CLAYMAN, CB1
PALMER, WL1

Other Studies

1 other study available for metyrapone and Crohn Disease

ArticleYear
ADRENOCORTICAL AND PITUITARY RESPONSIVENESS FOLLOWING LONG-TERM, HIGH DOSAGE ACTH AND STEROID TREATMENT OF PATIENTS WITH CHRONIC INTESTINAL DISORDERS.
    Acta gastro-enterologica Belgica, 1964, Volume: 27

    Topics: Adrenocorticotropic Hormone; Colitis; Colitis, Ulcerative; Crohn Disease; Enteritis; Humans; Intesti

1964